Source: Healthcare Weekly

Miromatrix: United Therapeutics Buys Miromatrix for $91M to Expand Organ Manufacturing

United Therapeutics Corporation and Miromatrix Medical Inc. announced October 30th a definitive agreement for United Therapeutics to acquire Miromatrix. Miromatrix is a life sciences company focused on the development of bioengineered organs composed of human cells. United Therapeutics is a biotechnology company with six FDA-approved therapies to address rare, life-threatening conditions, and a pipeline that [...]The post United Therapeutics Buys Miromatrix for $91M to Expand Organ Manufacturing appeared first on Healthcare Weekly.

Read full article »
Annual Revenue
$100K-5.0M
Employees
25-100
Jeff Ross's photo - CEO of Miromatrix

CEO

Jeff Ross

CEO Approval Rating

90/100

Read more